National Neonatal/Advanced Practice/Mother Baby Nurses Conference 2017

Neonatal Pharmacology, Part I

Sep 13, 2017 8:00am ‐ Sep 13, 2017 12:00pm


Credits: None available.

Standard: $50.00

Description

Continuing Nursing Education (CNE) Activity: Neonatal Pharmacology, Part I
 
Presenter(s): Christopher McPherson, PharmD
 
Total Contact Hours: 3.75 CH, 3.75 Rx
 
Intended Audience: All neonatal nurses
 
Purpose of this CNE activity: The Academy of Neonatal Nursing provides clinically current information on the technical, medical, and nursing aspects of neonatal care as well as the legal and ethical implications related to that care. This CNE activity provides information to nurses and other health care professionals who care for newborn, premature, and ill infants and their families. Specific objectives for this presentation are listed below.
 
Session Description: Dr. McPherson focuses on neonatal cardiovascular pharmacotherapy. Examine the challenges of assessing and treating hypoperfusion in the preterm infant. Compare medications used to treat patent ductus arteriosus in the newborn, and discuss the pharmacologic options for treating persistent pulmonary hypertension of the newborn. 

Objectives: Upon completion, learners will be able to:

  • Discuss the pharmacologic options for the treatment of neonatal hypoperfusion. 
  • Identify the risks and benefits of available agents to pharmacologically close a hemodynamically significant patent ductus arteriosus.
  • Describe pharmacologic options for the treatment of persistent pulmonary hypertension of the newborn and define a treatment algorithm based on available evidence.

Requirements for Completion: The following requirements are necessary for successful completion of this CNE activity.

  • Access to a computer with an Internet connection
  • Attend/view at least 90% of the session
  • Complete and submit the evaluation for this CNE activity

Accreditation
Provider, Academy of Neonatal Nursing, approved by the California Board of Registered Nursing, Provider #CEP 6261; and Florida Board of Nursing, Provider #FBN 3218, content code 2505.
 
The Academy of Neonatal Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
 
Release Date: September 13, 2017
Expiration Date: September 30, 2020
 
Disclosures:

  1. The lead nurse planner, the planning committee, and the author(s) of this activity disclose no relevant financial relationships.
  2. This CNE activity has been reviewed by the Lead Nurse Planner. It has been determined that the material presented here shows no bias.
  3. The content of this CNE activity has been developed by the planning committee and reviewed by the Lead Nurse Planner. The content has been deemed to reflect the current state of practice.

Disclaimer: The Academy of Neonatal Nursing assumes no responsibility or liability for the content presented. Care of the infant should always be individualized and no one source relied upon for information regarding aspects of care. Accredited status does not imply endorsement by ANN, ANA, or the American Nurses Credentialing Center of any commercial products displayed or discussed in conjunction with an educational activity.

Speaker(s):

Credits Available


Neonatal Pharmacology, Part I Exam

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
* - Indicates answer is required.
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content